Anticoagulant Reversal Drugs Market – 2022-2026 | Increasing Prevalence of Coagulation Disorders to Boost Market Growth | Technavio

NEW YORK, May 16, 2022 /PRNewswire/ — The “Anticoagulant Reversal Drugs Market report has been added to Technavio’s offering. The potential growth difference for the anticoagulant reversal drugs market from 2021 to 2026 is USD 877.37 million. To get the exact yearly growth variance and the Y-O-Y growth rate, Download Sample Report.

Key Market Dynamics:

  • Market Driver
  • Market Challenges

The rising frequency of coagulation diseases such as Von Willebrand disease, hemophilia, deep venous thrombosis, hypercoagulable states, and clotting factor deficiencies is one of the primary reasons driving the worldwide anticoagulant reversal medicines market growth. However, factors such as product recalls will challenge market growth.

To learn about additional key drivers, trends, and challenges available with TechnavioRead our Sample Report right now!

Key Market Segmentation
The anticoagulant reversal drugs market report is segmented by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Geography (North America, Europe, Asia, and the Rest of the World (ROW)). North America will be the leading region with 43% of the market’s growth during the forecast period. The US, Canada, UK, Germany, France, and China are the key market for anticoagulant reversal drugs in North America.

The hospital pharmacy sector will gain a considerable proportion of the anticoagulant reversal medicines market. This increase is due to an increase in the number of people being admitted to hospitals for serious illnesses or for basic monitoring after procedures, causing hospitals to boost their investments in hospital pharmacies.

View our sample report for additional insights into the contribution of all the segments, and regional opportunities in the report.

Some Companies Mentioned with their Offerings
The report analyzes the market’s competitive landscape and offers information on several market vendors, including: 

    • Amboss GmbH
    • Amneal Pharmaceuticals Inc.
    • AstraZeneca Plc
    • Bausch Health Companies Inc.
    • Boehringer Ingelheim International GmbH
    • Covis Pharma BV
    • CSL Ltd.
    • GoodRx Holdings Inc.
    • Midas Pharma GmbH
    • Pfizer Inc.

To gain access to more vendor profiles with their key offerings available with Technavio, Click Here

Geographical Market Analysis 
North America will account for 43 percent of market growth. In North America, anticoagulant reversal medicines are mostly sold in the United States and Canada. The market in this region will increase at a quicker rate than the market in other regions.

Over the forecast period, the availability of direct reimbursement policies and contemporary healthcare infrastructure will aid the expansion of the anticoagulant reversal medicines market in North America.

Know more about this market’s geographical distribution along with a detailed analysis of the top regions. Download Sample Report.

Customize Your Report 
Don’t miss out on the opportunity to speak to our analyst and know more insights about this market report. Our analysts can also help you customize this report according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

Do reach out to our analysts for more customized reports as per your requirements. Speak to our Analyst now! 

Related Reports:

Topical Drugs Market by Product and Geography – Forecast and Analysis 2022-2026

Autoimmune Hemolytic Anemia Therapeutics Market by Product and Geography – Forecast and Analysis 2022-2026

Anticoagulant Reversal Drugs Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 12.27%

Market growth 2022-2026

$ 877.37 million

Market structure

Fragmented

YoY growth (%)

12.0

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 43%

Key consumer countries

US, Canada, UK, Germany, France, and China

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Amboss GmbH, Amneal Pharmaceuticals Inc., AstraZeneca Plc, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, Covis Pharma BV, CSL Ltd., GoodRx Holdings Inc., Midas Pharma GmbH, and Pfizer Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
    • Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
    • Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
    • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
    • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
    • Exhibit 17: Five forces analysis – Comparison between2021 and 2026
  • 4.2 Bargaining power of buyers
    • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
    • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
    • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
    • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
    • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
  • 4.7 Market condition
    • Exhibit 23: Chart on Market condition – Five forces 2021 and 2026

5 Market Segmentation by Distribution Channel

  • 5.1 Market segments
    • Exhibit 24: Chart on Distribution Channel – Market share 2021-2026 (%)
    • Exhibit 25: Data Table on Distribution Channel – Market share 2021-2026 (%)
  • 5.2 Comparison by Distribution Channel
    • Exhibit 26: Chart on Comparison by Distribution Channel
    • Exhibit 27: Data Table on Comparison by Distribution Channel
  • 5.3 Hospital pharmacy – Market size and forecast 2021-2026
    • Exhibit 28: Chart on Hospital pharmacy – Market size and forecast 2021-2026 ($ million)
    • Exhibit 29: Data Table on Hospital pharmacy – Market size and forecast 2021-2026 ($ million)
    • Exhibit 30: Chart on Hospital pharmacy – Year-over-year growth 2021-2026 (%)
    • Exhibit 31: Data Table on Hospital pharmacy – Year-over-year growth 2021-2026 (%)
  • 5.4 Retail pharmacy – Market size and forecast 2021-2026
    • Exhibit 32: Chart on Retail pharmacy – Market size and forecast 2021-2026 ($ million)
    • Exhibit 33: Data Table on Retail pharmacy – Market size and forecast 2021-2026 ($ million)
    • Exhibit 34: Chart on Retail pharmacy – Year-over-year growth 2021-2026 (%)
    • Exhibit 35: Data Table on Retail pharmacy – Year-over-year growth 2021-2026 (%)
  • 5.5 Online pharmacy – Market size and forecast 2021-2026
    • Exhibit 36: Chart on Online pharmacy – Market size and forecast 2021-2026 ($ million)
    • Exhibit 37: Data Table on Online pharmacy – Market size and forecast 2021-2026 ($ million)
    • Exhibit 38: Chart on Online pharmacy – Year-over-year growth 2021-2026 (%)
    • Exhibit 39: Data Table on Online pharmacy – Year-over-year growth 2021-2026 (%)
  • 5.6 Market opportunity by Distribution Channel
    • Exhibit 40: Market opportunity by Distribution Channel ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
    • Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
    • Exhibit 42: Chart on Market share by geography 2021-2026 (%)
    • Exhibit 43: Data Table on Market share by geography 2021-2026 (%)
  • 7.2 Geographic comparison
    • Exhibit 44: Chart on Geographic comparison
    • Exhibit 45: Data Table on Geographic comparison
  • 7.3 North America – Market size and forecast 2021-2026
    • Exhibit 46: Chart on North America – Market size and forecast 2021-2026 ($ million)
    • Exhibit 47: Data Table on North America – Market size and forecast 2021-2026 ($ million)
    • Exhibit 48: Chart on North America – Year-over-year growth 2021-2026 (%)
    • Exhibit 49: Data Table on North America – Year-over-year growth 2021-2026 (%)
  • 7.4 Europe – Market size and forecast 2021-2026
    • Exhibit 50: Chart on Europe – Market size and forecast 2021-2026 ($ million)
    • Exhibit 51: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
    • Exhibit 52: Chart on Europe – Year-over-year growth 2021-2026 (%)
    • Exhibit 53: Data Table on Europe – Year-over-year growth 2021-2026 (%)
  • 7.5 Asia – Market size and forecast 2021-2026
    • Exhibit 54: Chart on Asia – Market size and forecast 2021-2026 ($ million)
    • Exhibit 55: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
    • Exhibit 56: Chart on Asia – Year-over-year growth 2021-2026 (%)
    • Exhibit 57: Data Table on Asia – Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) – Market size and forecast 2021-2026
    • Exhibit 58: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
    • Exhibit 59: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
    • Exhibit 60: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
    • Exhibit 61: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
  • 7.7 US – Market size and forecast 2021-2026
    • Exhibit 62: Chart on US – Market size and forecast 2021-2026 ($ million)
    • Exhibit 63: Data Table on US – Market size and forecast 2021-2026 ($ million)
    • Exhibit 64: Chart on US – Year-over-year growth 2021-2026 (%)
    • Exhibit 65: Data Table on US – Year-over-year growth 2021-2026 (%)
  • 7.8 UK – Market size and forecast 2021-2026
    • Exhibit 66: Chart on UK – Market size and forecast 2021-2026 ($ million)
    • Exhibit 67: Data Table on UK – Market size and forecast 2021-2026 ($ million)
    • Exhibit 68: Chart on UK – Year-over-year growth 2021-2026 (%)
    • Exhibit 69: Data Table on UK – Year-over-year growth 2021-2026 (%)
  • 7.9 Canada – Market size and forecast 2021-2026
    • Exhibit 70: Chart on Canada – Market size and forecast 2021-2026 ($ million)
    • Exhibit 71: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
    • Exhibit 72: Chart on Canada – Year-over-year growth 2021-2026 (%)
    • Exhibit 73: Data Table on Canada – Year-over-year growth 2021-2026 (%)
  • 7.10 Germany – Market size and forecast 2021-2026
    • Exhibit 74: Chart on Germany – Market size and forecast 2021-2026 ($ million)
    • Exhibit 75: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
    • Exhibit 76: Chart on Germany – Year-over-year growth 2021-2026 (%)
    • Exhibit 77: Data Table on Germany – Year-over-year growth 2021-2026 (%)
  • 7.11 China – Market size and forecast 2021-2026
    • Exhibit 78: Chart on China – Market size and forecast 2021-2026 ($ million)
    • Exhibit 79: Data Table on China – Market size and forecast 2021-2026 ($ million)
    • Exhibit 80: Chart on China – Year-over-year growth 2021-2026 (%)
    • Exhibit 81: Data Table on China – Year-over-year growth 2021-2026 (%)
  • 7.12 France – Market size and forecast 2021-2026
    • Exhibit 82: Chart on France – Market size and forecast 2021-2026 ($ million)
    • Exhibit 83: Data Table on France – Market size and forecast 2021-2026 ($ million)
    • Exhibit 84: Chart on France – Year-over-year growth 2021-2026 (%)
    • Exhibit 85: Data Table on France – Year-over-year growth 2021-2026 (%)
  • 7.13 Market opportunity by geography
    • Exhibit 86: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
    • Exhibit 87: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
    • Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
    • Exhibit 89: Overview on factors of disruption
  • 9.4 Industry risks
    • Exhibit 90: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
    • Exhibit 91: Vendors covered
  • 10.2 Market positioning of vendors
    • Exhibit 92: Matrix on vendor position and classification
  • 10.3 Amboss GmbH
    • Exhibit 93: Amboss GmbH – Overview
    • Exhibit 94: Amboss GmbH – Product / Service
    • Exhibit 95: Amboss GmbH – Key offerings
  • 10.4 Amneal Pharmaceuticals Inc.
    • Exhibit 96: Amneal Pharmaceuticals Inc. – Overview
    • Exhibit 97: Amneal Pharmaceuticals Inc. – Business segments
    • Exhibit 98: Amneal Pharmaceuticals Inc. – Key news
    • Exhibit 99: Amneal Pharmaceuticals Inc. – Key offerings
    • Exhibit 100: Amneal Pharmaceuticals Inc. – Segment focus
  • 10.5 AstraZeneca Plc
    • Exhibit 101: AstraZeneca Plc – Overview
    • Exhibit 102: AstraZeneca Plc – Product / Service
    • Exhibit 103: AstraZeneca Plc – Key news
    • Exhibit 104: AstraZeneca Plc – Key offerings
  • 10.6 Bausch Health Companies Inc.
    • Exhibit 105: Bausch Health Companies Inc. – Overview
    • Exhibit 106: Bausch Health Companies Inc. – Business segments
    • Exhibit 107: Bausch Health Companies Inc. – Key news
    • Exhibit 108: Bausch Health Companies Inc. – Key offerings
    • Exhibit 109: Bausch Health Companies Inc. – Segment focus
  • 10.7 Boehringer Ingelheim International GmbH
    • Exhibit 110: Boehringer Ingelheim International GmbH – Overview
    • Exhibit 111: Boehringer Ingelheim International GmbH – Business segments
    • Exhibit 112: Boehringer Ingelheim International GmbH – Key news
    • Exhibit 113: Boehringer Ingelheim International GmbH – Key offerings
    • Exhibit 114: Boehringer Ingelheim International GmbH – Segment focus
  • 10.8 Covis Pharma BV
    • Exhibit 115: Covis Pharma BV – Overview
    • Exhibit 116: Covis Pharma BV – Product / Service
    • Exhibit 117: Covis Pharma BV – Key offerings
  • 10.9 CSL Ltd.
    • Exhibit 118: CSL Ltd. – Overview
    • Exhibit 119: CSL Ltd. – Business segments
    • Exhibit 120: CSL Ltd. – Key news
    • Exhibit 121: CSL Ltd. – Key offerings
    • Exhibit 122: CSL Ltd. – Segment focus
  • 10.10 GoodRx Holdings Inc.
    • Exhibit 123: GoodRx Holdings Inc. – Overview
    • Exhibit 124: GoodRx Holdings Inc. – Product / Service
    • Exhibit 125: GoodRx Holdings Inc. – Key offerings
  • 10.11 Midas Pharma GmbH
    • Exhibit 126: Midas Pharma GmbH – Overview
    • Exhibit 127: Midas Pharma GmbH – Product / Service
    • Exhibit 128: Midas Pharma GmbH – Key offerings
  • 10.12 Pfizer Inc.
    • Exhibit 129: Pfizer Inc. – Overview
    • Exhibit 130: Pfizer Inc. – Product / Service
    • Exhibit 131: Pfizer Inc. – Key news
    • Exhibit 132: Pfizer Inc. – Key offerings

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
    • Exhibit 133: Inclusions checklist
    • Exhibit 134: Exclusions checklist
  • 11.3 Currency conversion rates for US$
    • Exhibit 135: Currency conversion rates for US$
  • 11.4 Research methodology
    • Exhibit 136: Research methodology
    • Exhibit 137: Validation techniques employed for market sizing
    • Exhibit 138: Information sources
  • 11.5 List of abbreviations
    • Exhibit 139: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email:[email protected]
Website: www.technavio.com/

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/anticoagulant-reversal-drugs-market—2022-2026–increasing-prevalence-of-coagulation-disorders-to-boost-market-growth–technavio-301546977.html

SOURCE Technavio

Anticoagulant Reversal Drugs Market - 2022-2026 | Increasing Prevalence of Coagulation Disorders to Boost Market Growth | Technavio WeeklyReviewer

PR Newswire Science News

Earnings Disclosure

WeeklyReviewer earns primarily through affiliates and ads. We don’t encourage anyone to click on ads for any other purpose but your own. We recommend products and services often for our readers, and through many we will earn commissions through affiliate programs.

WeeklyReviewer earns commissions through affiliates of qualifying products through Amazon Associates, Fiverr Affiliates, Hostgator Affiliates, Namecheap Affiliates, NordVPN Affiliates, Semrush Affiliates, Alibaba Affiliates, Clickfunnels Affiliate, Leadpages Affiliates, Cryptohopper Affiliates, Binance Affiliates and more.

Clicking on links in WeeklyReviewer may or may not provide us commission through any qualifying purchases.

World Reviewer Staff
World Reviewer Staffhttps://weeklyreviewer.com/
The first logical thought has to be "no way". I'm the World Observer! Ill find and share important news all day.

Latest articles

Related articles

WeeklyReviewer